Literature DB >> 19092406

Living-related conjunctival-limbal allograft for chronic or delayed-onset mustard gas keratopathy.

Mohammad-Ali Javadi1, Alireza Baradaran-Rafii.   

Abstract

PURPOSE: To determine the long-term outcomes of living-related stem cell transplantation in patients with delayed or chronic mustard gas keratopathy (MGK).
MATERIALS AND METHODS: In this noncomparative interventional case series, 21 consecutive patients with advanced delayed or chronic MGK received living-related conjunctival-limbal allograft and were followed up for at least 1 year. All subjects received immunosuppression with systemic cyclosporine. Main outcome measures were reduction of subjective complaints, corneal epithelial healing, and regression of corneal neovascularization adjacent to the transplant area.
RESULTS: Twenty-five eyes of 21 patients (all male), including 4 patients who received bilateral grafts, were operated. Mean age at the time of surgery was 35.8 +/- 3.8 years, mean interval between mustard gas exposure and surgery was 12.2 +/- 3.5 years, and mean follow-up was 37.2 +/- 18.5 months. Average size of the donor lenticule was 71.16 +/- 17.34 degrees. Simultaneous penetrating and lamellar keratoplasty were performed in 5 and 2 eyes, respectively. All patients consistently reported marked subjective improvement. Mean time for epithelial healing was 7.76 +/- 3.2 days. Visual acuity was 1.35 +/- 0.81 LogMAR before surgery, which improved to 0.59 +/- 0.34 LogMAR 3 months after the procedure (P < 0.001). Mean visual acuity at final examination was 0.82 +/- 0.49 LogMAR (P = 0.001). Acute stem cell rejection was observed in 10 (40%) eyes, which improved by increasing the dose of topical and systemic steroids. Chronic stem cell rejection was diagnosed in 8 (32%) eyes, which led to failure in 5 (20%) eyes.
CONCLUSIONS: Living-related conjunctival-limbal allograft is effective in stabilizing the ocular surface in patients with delayed or chronic MGK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19092406     DOI: 10.1097/ICO.0b013e3181852673

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  12 in total

1.  Doxycycline hydrogels as a potential therapy for ocular vesicant injury.

Authors:  Marion K Gordon; Andrea Desantis; Manjeet Deshmukh; Carl Jeffrey Lacey; Rita A Hahn; John Beloni; Sivanaga S Anumolu; John J Schlager; Michael A Gallo; Donald R Gerecke; Ned D Heindel; Kathy K H Svoboda; Michael C Babin; Patrick J Sinko
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

Review 2.  Stem cell and tissue engineering research in the Islamic republic of Iran.

Authors:  Yousof Gheisari; Hossein Baharvand; Karim Nayernia; Mohammad Vasei
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 3.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

Review 4.  Ocular toxicity of mustard gas: A concise review.

Authors:  Allison Fuchs; Elizabeth A Giuliano; Nishant R Sinha; Rajiv R Mohan
Journal:  Toxicol Lett       Date:  2021-02-15       Impact factor: 4.271

Review 5.  The Ocular Surface and How It Can Influence the Outcomes of Keratoprosthesis.

Authors:  Sarah Moussa; Herbert Reitsamer; Josef Ruckhofer; Günther Grabner
Journal:  Curr Ophthalmol Rep       Date:  2016-11-05

6.  Clinical Practice Guidelines for Prevention, Diagnosis and Management of Early and Delayed-onset Ocular Injuries Due to Mustard Gas Exposure.

Authors:  Zhale Rajavi; Sare Safi; Mohammad Ali Javadi; Mohammad Reza Jafarinasab; Sepehr Feizi; Mohammadreza Sedighi Moghadam; Khosrow Jadidi; Mahmoud Babaei; Armin Shirvani; Alireza Baradaran-Rafii; Hossein Mohammad-Rabei; Hossein Ziaei; Mohammad Ghassemi-Broumand; Siamak Delfaza Baher; Mostafa Naderi; Mahmoodreza Panahi-Bazaz; Siamak Zarei-Ghanavati; Shahriar Hanjani; Hassan Ghasemi; Ramin Salouti; Mojgan Pakbin; Bahareh Kheiri
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

Review 7.  The promise of stem cell-based therapeutics in ophthalmology.

Authors:  Israel Aharony; Shalom Michowiz; Nitza Goldenberg-Cohen
Journal:  Neural Regen Res       Date:  2017-02       Impact factor: 5.135

8.  Mustard gas induced ocular surface disorders.

Authors:  Alireza Baradaran-Rafii; Mohammad-Ali Javadi; Farid Karimian; Sepehr Feizi
Journal:  J Ophthalmic Vis Res       Date:  2013-10

Review 9.  Transforming ocular surface stem cell research into successful clinical practice.

Authors:  Virender S Sangwan; Rajat Jain; Sayan Basu; Anupam B Bagadi; Shraddha Sureka; Indumathi Mariappan; Sheila Macneil
Journal:  Indian J Ophthalmol       Date:  2014-01       Impact factor: 1.848

Review 10.  The ocular surface chemical burns.

Authors:  Medi Eslani; Alireza Baradaran-Rafii; Asadolah Movahedan; Ali R Djalilian
Journal:  J Ophthalmol       Date:  2014-07-01       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.